Structural evolution of the emerging 2014-2015 GII.17 noroviruses

Journal of Virology

Volumn 90, Issue 5, 2016, Pages 2710-2715

  Singh, Bishal Kumar ^a   Koromyslova, Anna ^a   Hefele, Lisa ^a   Gürth, Clara ^a   Hansman, Grant S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; VIRUS ANTIBODY;

AMINO ACID SUBSTITUTION; ARTICLE; CROSS REACTION; CRYSTAL STRUCTURE; EVOLUTION; NONHUMAN; NOROVIRUS; NOROVIRUS GENOGROUP II GENOTYPE 17; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS CAPSID; VIRUS STRAIN; AMINO ACID SEQUENCE; CALICIVIRUS INFECTION; CHEMISTRY; CLASSIFICATION; GENETIC VARIATION; GENETICS; GENOTYPE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR EVOLUTION; MOLECULAR GENETICS; MOLECULAR MODEL; PROTEIN CONFORMATION; VIROLOGY; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBODIES, VIRAL; CALICIVIRIDAE INFECTIONS; CAPSID; CROSS REACTIONS; CRYSTALLOGRAPHY, X-RAY; EVOLUTION, MOLECULAR; GENETIC VARIATION; GENOTYPE; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NOROVIRUS; PROTEIN CONFORMATION;

EID: 84961128949     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03119-15     Document Type: Article

References (33)

1. Siebenga JJ, Lemey P, Kosakovsky Pond SL, Rambaut A, Vennema H, Koopmans M. 2010. Phylodynamic reconstruction reveals norovirus GII.4 epidemic expansions and their molecular determinants. PLoS Pathog 6:e1000884. http://dx.doi.org/10.1371/journal.ppat.1000884.
2. Siebenga JJ, Vennema H, Renckens B, de Bruin E, van der Veer B, Siezen RJ, Koopmans M. 3 July 2007. Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J Virol.
3. Noel JS, Fankhauser RL, Ando T, Monroe SS, Glass RI. 1999. Identification of a distinct common strain of "Norwalk-like viruses" having a global distribution. J Infect Dis 179:1334-1344. http://dx.doi.org/10.1086/314783.
4. Zhang XF, Huang Q, Long Y, Jiang X, Zhang T, Tan M, Zhang QL, Huang ZY, Li YH, Ding YQ, Hu GF, Tang S, Dai YC. 2015. An outbreak caused by GII.17 norovirus with a wide spectrum of HBGA-associated susceptibility. Sci Rep 5:17687. http://dx.doi.org/10.1038/srep17687.
5. Matsushima Y, Ishikawa M, Shimizu T, Komane A, Kasuo S, Shinohara M, Nagasawa K, Kimura H, Ryo A, Okabe N, Haga K, Doan YH, Katayama K, Shimizu H. 2015. Genetic analyses of GII.17 norovirus strains in diarrheal disease outbreaks from December 2014 to March 2015 in Japan reveal a novel polymerase sequence and amino acid substitutions in the capsid region. Euro Surveill 20:pii=21173. http://dx.doi.org/10.2807/1560-7917.ES2015.20.26.21173.
6. Lee CC, Feng Y, Chen SY, Tsai CN, Lai MW, Chiu CH. 1 December 2015, posting date. Emerging norovirus GII.17 in Taiwan. Clin Infect Dis http://dx.doi.org/10.1093/cid/civ647.
7. Fu J, Ai J, Jin M, Jiang C, Zhang J, Shi C, Lin Q, Yuan Z, Qi X, Bao C, Tang F, Zhu Y. 2015. Emergence of a new GII.17 norovirus variant in patients with acute gastroenteritis in Jiangsu, China, September 2014 to March 2015. Euro Surveill 20:pii=21157. http://dx.doi.org/10.2807/1560-7917.ES2015.20.24.21157.
8. Chan MC, Lee N, Hung TN, Kwok K, Cheung K, Tin EK, Lai RW, Nelson EA, Leung TF, Chan PK. 2015. Rapid emergence and predominance of a broadly recognizing and fast-evolving norovirus GII.17 variant in late 2014. Nat Commun 6:10061. http://dx.doi.org/10.1038/ncomms10061.
9. Rackoff LA, Bok K, Green KY, Kapikian AZ. 2013. Epidemiology and evolution of rotaviruses and noroviruses from an archival WHO Global Study in Children (1976-79) with implications for vaccine design. PLoS One 8:e59394. http://dx.doi.org/10.1371/journal.pone.0059394.
10. Nenonen NP, Hannoun C, Svensson L, Toren K, Andersson LM, Westin J, Bergstrom T. 2014. Norovirus GII.4 detection in environmental samples from patient rooms during nosocomial outbreaks. J Clin Microbiol 52:2352-2358. http://dx.doi.org/10.1128/JCM.00266-14.
11. Xi JN, Graham DY, Wang KN, Estes MK. 1990. Norwalk virus genome cloning and characterization. Science 250:1580-1583. http://dx.doi.org/10.1126/science.2177224.
12. Prasad BV, Hardy ME, Dokland T, Bella J, Rossmann MG, Estes MK. 1999. X-ray crystallographic structure of the Norwalk virus capsid. Science 286:287-290. http://dx.doi.org/10.1126/science.286.5438.287.
13. Huang P, Farkas T, Marionneau S, Zhong W, Ruvoen-Clouet N, Morrow AL, Altaye M, Pickering LK, Newburg DS, LePendu J, Jiang X. 2003. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis 188:19-31. http://dx.doi.org/10.1086/375742.
14. Huang P, Farkas T, Zhong W, Tan M, Thornton S, Morrow AL, Jiang X. 2005. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol 79:6714-6722. http://dx.doi.org/10.1128/JVI.79.11.6714-6722.2005.
15. Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS. 2002. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol 76:12335-12343. http://dx.doi.org/10.1128/JVI.76.23.12335-12343.2002.
16. Rockx BH, Vennema H, Hoebe CJ, Duizer E, Koopmans MP. 2005. Association of histo-blood group antigens and susceptibility to norovirus infections. J Infect Dis 191:749-754. http://dx.doi.org/10.1086/427779.
17. Lindesmith LC, Donaldson EF, Baric RS. 2011. Norovirus GII.4 strain antigenic variation. J Virol 85:231-242. http://dx.doi.org/10.1128/JVI.01364-10.
18. Debbink K, Lindesmith LC, Donaldson EF, Baric RS. 2012. Norovirus immunity and the great escape. PLoS Pathog 8:e1002921. http://dx.doi.org/10.1371/journal.ppat.1002921.
19. Atmar RL, Bernstein DI, Harro CD, Al-Ibrahim MS, Chen WH, Ferreira J, Estes MK, Graham DY, Opekun AR, Richardson C, Mendelman PM. 2011. Norovirus vaccine against experimental human Norwalk virus illness. N Engl J Med 365:2178-2187. http://dx.doi.org/10.1056/NEJMoa1101245.
20. Tan M, Huang P, Xia M, Fang PA, Zhong W, McNeal M, Wei C, Jiang W, Jiang X. 2011. Norovirus P particle, a novel platform for vaccine development and antibody production. J Virol 85:753-764. http://dx.doi.org/10.1128/JVI.01835-10.
21. Atmar RL, Estes MK. 2012. Norovirus vaccine development: next steps. Expert Rev Vaccines 11:1023-1025. http://dx.doi.org/10.1586/erv.12.78.
22. Hansman GS, Biertumpfel C, Georgiev I, McLellan JS, Chen L, Zhou T, Katayama K, Kwong PD. 2011. Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability. J Virol 85:6687-6701. http://dx.doi.org/10.1128/JVI.00246-11.
23. Hansman GS, Natori K, Shirato-Horikoshi H, Ogawa S, Oka T, Katayama K, Tanaka T, Miyoshi T, Sakae K, Kobayashi S, Shinohara M, Uchida K, Sakurai N, Shinozaki K, Okada M, Seto Y, Kamata K, Nagata N, Tanaka K, Miyamura T, Takeda N. 2006. Genetic and antigenic diversity among noroviruses. J Gen Virol 87:909-919. http://dx.doi.org/10.1099/vir.0.81532-0.
24. Singh BK, Leuthold MM, Hansman GS. 2015. Human noroviruses' fondness for histo-blood group antigens. J Virol 89:2024-2040. http://dx.doi.org/10.1128/JVI.02968-14.
25. Kabsch W. 1993. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J Appl Crystallogr 26:795-800. http://dx.doi.org/10.1107/S0021889893005588.
26. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. 2007. Phaser crystallographic software. J Appl Crystallogr 40: 658-674. http://dx.doi.org/10.1107/S0021889807021206.
27. Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, Kiefer F, Cassarino TG, Bertoni M, Bordoli L, Schwede T. 2014. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res 42:W252-W258. http://dx.doi.org/10.1093/nar/gku340.
28. Adams PD, Afonine PV, Bunkóczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung L-W, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66:213-221. http://dx.doi.org/10.1107/S0907444909052925.
29. Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66:486-501. http://dx.doi.org/10.1107/S0907444910007493.
30. Chen VB, Arendall WB, III, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. 2010. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66:12-21. http://dx.doi.org/10.1107/S0907444909042073.
31. Krissinel E, Henrick K. 2007. Inference of macromolecular assemblies from crystalline state. J Mol Biol 372:774-797. http://dx.doi.org/10.1016/j.jmb.2007.05.022.
32. Tan M, Xia M, Cao S, Huang P, Farkas T, Meller J, Hegde RS, Li X, Rao Z, Jiang X. 2008. Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study. Virology 379:324-334. http://dx.doi.org/10.1016/j.virol.2008.06.041.
33. Debbink K, Lindesmith LC, Donaldson EF, Costantini V, Beltramello M, Corti D, Swanstrom J, Lanzavecchia A, Vinje J, Baric RS. 1 August 2013, posting date. Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity. J Infect Dis http://dx.doi.org/10.1093/infdis/jit370.